Form 8-K - Current report:
SEC Accession No. 0001683168-25-002373
Filing Date
2025-04-09
Accepted
2025-04-09 15:32:24
Documents
35
Period of Report
2025-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm   iXBRL 8-K 28285
5 PRESENTATION DATED APRIL 2025 cns_ex9901.htm EX-99.1 30855
6 GRAPHIC image_023.jpg GRAPHIC 31380
7 GRAPHIC image_024.jpg GRAPHIC 103172
8 GRAPHIC image_033.jpg GRAPHIC 52908
9 GRAPHIC image_026.jpg GRAPHIC 57178
10 GRAPHIC image_034.jpg GRAPHIC 60744
11 GRAPHIC image_028.jpg GRAPHIC 70092
12 GRAPHIC image_029.jpg GRAPHIC 62672
13 GRAPHIC image_030.jpg GRAPHIC 71793
14 GRAPHIC image_031.jpg GRAPHIC 33805
15 GRAPHIC image_035.jpg GRAPHIC 53150
16 GRAPHIC image_036.jpg GRAPHIC 57417
17 GRAPHIC image_037.jpg GRAPHIC 42530
18 GRAPHIC image_039.jpg GRAPHIC 53762
19 GRAPHIC image_040.jpg GRAPHIC 34158
20 GRAPHIC image_041.jpg GRAPHIC 61240
21 GRAPHIC image_042.jpg GRAPHIC 43652
22 GRAPHIC image_043.jpg GRAPHIC 48439
23 GRAPHIC image_044.jpg GRAPHIC 56961
24 GRAPHIC image_045.jpg GRAPHIC 69467
25 GRAPHIC image_046.jpg GRAPHIC 30983
26 GRAPHIC image_047.jpg GRAPHIC 52935
  Complete submission text file 0001683168-25-002373.txt   1825593

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cnsp-20250409.xsd EX-101.SCH 3017
3 XBRL LABEL FILE cnsp-20250409_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cnsp-20250409_pre.xml EX-101.PRE 22360
37 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 25825072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)